Skip to main content
. 2014 Nov 25;9(11):e112883. doi: 10.1371/journal.pone.0112883

Figure 1. Binding affinities and in vivo activities of human insulin and [GlnB22]-insulin.

Figure 1

(A) Inhibition of the binding of human [125I]-insulin to the plasma membrane of IM-9 cells by human insulin (blue) and [GlnB22]-insulin (red). (B) Insulin tolerance test of human insulin (blue) and [GlnB22]-insulin (red). Values are mean ±S.E., n = 10/group. ***p<0.01 compared to human insulin-treated group. Δ cM is the decrease in molar concentration of blood glucose in mmol/l adjusted for the impact of conditions during testing (represented by the application of saline).